PHILADELPHIA and VANCOUVER, British Columbia, Sept. 14, 2022 BriaCell Therapeutics Corp. , a clinical-stage biotechnology company specializing in targeted immunotherapies for cancer, announces. | September 14, 2022
/PRNewswire/ Pyramid Biosciences, Inc., and Caris Life Sciences® (Caris), today announced a collaboration to enhance identification of potential patients.
/PRNewswire/ Pyramid Biosciences, Inc., and Caris Life Sciences® (Caris), today announced a collaboration to enhance identification of potential patients.